top of page

Client Stories 

Our Private Equity client required expertise on CRO and FSP market, potential assets for investments and detailed evaluation & due diligence of selected assets 

​

We advised our PE client on the trends and challenges in clinical operations and clinical data sciences, CRO & FSP supplier space, and challenges and opportunities.   

 

  • We shared trends, challenges and opportunities with a particular focus on CROs and data focused CROs / Functional Service Providers (FSP), based on our work with clients across pharma, service providers and technology (SaaS) providers in the R&D space.​

​​

  • Based on our experience in working with numerous suppliers in this space, we evaluated few of the potential companies that they can invest in and actively participated in the initial screening, financial due diligence, valuation analysis, competitive positioning, potential challenges and value creation opportunities. 

 

  • Post due diligence, we collaborated and developed the business case and recommended the PE firm to pursue advanced discussions with one of the companies.  We also recommended that they not proceed further with the other asset that had significant risk associated with their revenue consolidation with just a couple of clients.

Are you a Private Equity or Venture Capital firm interested in investing in start up / mid-market life sciences services (CRO, FSP, IT) or SaaS companies and have questions on the optimal selection?  Our experts can help ! 

bottom of page